Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction

Glutamate neurotransmission: A weakness for omega-3 Depletion of omega-3 fatty acids in a mouse model of schizophrenia with altered glutamate transmission has a lethal effect in males. Previous studies have suggested that omega-3 supplements may improve the symptoms of schizophrenia. Amy Ramsey and...

Full description

Saved in:
Bibliographic Details
Main Authors: Rehnuma Islam, Marc-Olivier Trépanier, Marija Milenkovic, Wendy Horsfall, Ali Salahpour, Richard P. Bazinet, Amy J. Ramsey
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Online Access:https://doaj.org/article/cb4d223a6c6e4da884ca01d7933a7b64
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glutamate neurotransmission: A weakness for omega-3 Depletion of omega-3 fatty acids in a mouse model of schizophrenia with altered glutamate transmission has a lethal effect in males. Previous studies have suggested that omega-3 supplements may improve the symptoms of schizophrenia. Amy Ramsey and colleagues at the University of Toronto, Canada, show in an established genetic mouse model of the disease that omega-3 dietary supplementation increased brain omega-3 levels, but did not have any beneficial effects on features that mirror symptoms of patients with schizophrenia such as increased locomotor activity or reduced social behavior. Interestingly, omega-3 dietary depletion worsened the cognitive performance and drastically increased the mortality rate of male mutant mice. The mechanisms responsible for these effects remain to be determined, but the findings highlight a potentially serious vulnerability of patients to dietary omega-3 deficits.